Location: New York, NY
CIK: 0001482416 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 13, 2025
Total Value: $395M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| MMS | MAXIMUS INC | 557,615 | $50.95M | 12.9% | $91.37 * | $80.51 | +0.6% | COM | 577933104 |
| CELC | CELCUITY INC | 786,526 | $38.85M | 9.8% | $49.40 * | $40.03 | 0.0% | COM | 15102K100 |
| SNY | SANOFI SA | 562,703 | $26.56M | 6.7% | $47.20 | $47.57 | — | SPONSORED ADR | 80105N105 |
| DNTH | DIANTHUS THERAPEUTICS INC | 577,750 | $22.73M | 5.8% | $39.35 * | $23.44 | +9.0% | COM | 252828108 |
| ALKS | ALKERMES PLC | 674,840 | $20.25M | 5.1% | $30.00 * | $28.20 | 0.0% | SHS | G01767105 |
| IRON | DISC MEDICINE INC | 284,787 | $18.82M | 4.8% | $66.08 * | $43.62 | +36.4% | COM | 254604101 |
| MRK | MERCK & CO INC | 177,300 | $14.88M | 3.8% | $83.93 * | $89.95 | -9.9% | COM | 58933Y105 |
| HSIC | HENRY SCHEIN INC | 219,207 | $14.55M | 3.7% | $66.37 * | $69.22 | 0.0% | COM | 806407102 |
| CNC | CENTENE CORP DEL | 387,600 | $13.83M | 3.5% | $35.68 * | $49.47 | -38.9% | COM | 15135B101 |
| KVUE | KENVUE INC | 844,000 | $13.7M | 3.5% | $16.23 * | $20.06 | 0.0% | COM | 49177J102 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 225,114 | $12.19M | 3.1% | $54.16 * | $64.15 | -10.8% | COM | 09061G101 |
| GSK | GSK PLC | 268,873 | $11.6M | 2.9% | $43.16 | $43.16 | — | SPONSORED ADR | 37733W204 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 190,764 | $11.57M | 2.9% | $60.66 * | $35.35 | +9.8% | COM NEW | 10919W405 |
| HAE | HAEMONETICS CORP MASS | 198,035 | $9.652M | 2.4% | $48.74 * | $61.90 | 0.0% | COM | 405024100 |
| AQST | AQUESTIVE THERAPEUTICS INC | 1,498,095 | $8.374M | 2.1% | $5.59 * | $3.44 | +25.5% | COM | 03843E104 |
| KALV | KALVISTA PHARMACEUTICALS INC | 683,819 | $8.329M | 2.1% | $12.18 * | $13.82 | 0.0% | COM | 483497103 |
| AVR | ANTERIS TECHNOLOGIES GLOBAL | 1,772,601 | $7.977M | 2.0% | $4.50 * | $5.59 | -29.9% | COM | 03675P102 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 174,841 | $7.282M | 1.8% | $41.65 * | $31.97 | 0.0% | COM | 22663K107 |
| TYRA | TYRA BIOSCIENCES INC | 514,947 | $7.204M | 1.8% | $13.99 * | $12.32 | -7.5% | COM | 90240B106 |
| RAPP | RAPPORT THERAPEUTICS INC | 185,265 | $5.502M | 1.4% | $29.70 * | $17.84 | 0.0% | COM | 75383L102 |
| NVCR | NOVOCURE LTD | 413,829 | $5.347M | 1.4% | $12.92 * | $13.36 | 0.0% | ORD SHS | G6674U108 |
| ANIP | ANI PHARMACEUTICALS INC | 55,723 | $5.104M | 1.3% | $91.60 * | $59.16 | +37.8% | COM | 00182C103 |
| EWTX | EDGEWISE THERAPEUTICS INC | 307,181 | $4.982M | 1.3% | $16.22 * | $14.42 | -1.6% | COM | 28036F105 |
| TFX | TELEFLEX INCORPORATED | 40,057 | $4.901M | 1.2% | $122.36 | $120.66 | 0.0% | COM | 879369106 |
| SLP | SIMULATIONS PLUS INC | 320,307 | $4.827M | 1.2% | $15.07 * | $14.54 | 0.0% | COM | 829214105 |
| PRQR | PROQR THERAPEUTICS N V | 2,075,139 | $4.42M | 1.1% | $2.13 * | $3.16 | -30.9% | SHS EURO | N71542109 |
| SI | SHOULDER INNOVATIONS INC | 350,000 | $4.393M | 1.1% | $12.55 * | $13.97 | 0.0% | COMMON STOCK | 82537J108 |
| PMVP | PMV PHARMACEUTICALS INC | 2,636,548 | $3.691M | 0.9% | $1.40 | $1.73 | -19.9% | COM | 69353Y103 |
| SEPN | SEPTERNA INC | 189,199 | $3.559M | 0.9% | $18.81 * | $15.63 | -16.0% | COM | 81734D104 |
| IDYA | IDEAYA BIOSCIENCES INC | 124,230 | $3.38M | 0.9% | $27.21 * | $37.74 | -35.9% | COM | 45166A102 |
| ALGS | ALIGOS THERAPEUTICS INC | 335,937 | $3.292M | 0.8% | $9.80 * | $14.55 | -37.2% | COM NEW | 01626L204 |
| ERAS | ERASCA INC | 1,369,748 | $2.986M | 0.8% | $2.18 * | $2.02 | -21.1% | COM | 29479A108 |
| VIR | VIR BIOTECHNOLOGY INC | 478,343 | $2.731M | 0.7% | $5.71 * | $7.89 | -35.2% | COM | 92764N102 |
| SVRA | SAVARA INC | 726,851 | $2.595M | 0.7% | $3.57 * | $2.76 | +7.0% | COM | 805111101 |
| VTYX | VENTYX BIOSCIENCES INC | 829,178 | $2.579M | 0.7% | $3.11 * | $2.68 | -1.1% | COM | 92332V107 |
| NMTC | NEUROONE MED TECHNOLOGIES CO | 2,360,635 | $2.098M | 0.5% | $0.89 * | $0.62 | +32.6% | COM NEW | 64130M209 |
| OVID | OVID THERAPEUTICS INC | 1,427,495 | $1.856M | 0.5% | $1.30 * | $0.84 | +3.1% | COM | 690469101 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 130,628 | $1.513M | 0.4% | $11.58 | $11.58 | — | COM NEW | 107924102 |
| CNTX | CONTEXT THERAPEUTICS INC | 1,341,636 | $1.3M | 0.3% | $0.97 * | $1.71 | -52.7% | COM | 21077P108 |
| — | SENSEONICS HOLDINGS INC | 2,315,749 | $1.009M | 0.3% | $0.44 | $0.48 | — | COM | 81727U105 |
| TELA | TELA BIO INC | 636,300 | $948K | 0.2% | $1.49 * | $2.80 | -37.0% | COM | 872381108 |
| AVTX | AVALO THERAPEUTICS INC | 72,173 | $917K | 0.2% | $12.71 * | $11.82 | -27.3% | COM NEW | 05338F306 |
| FHTX | FOGHORN THERAPEUTICS INC | 122,889 | $601K | 0.2% | $4.89 * | $4.31 | +22.9% | COM | 344174107 |
| MODD | MODULAR MED INC | 785,824 | $550K | 0.1% | $0.70 | $1.38 | -47.8% | COM NEW | 60785L207 |
| NYXH | NYXOAH S A | 50,839 | $234K | 0.1% | $4.60 * | $7.82 | -16.3% | SHS | B6S7WD106 |
| BOLD | BOUNDLESS BIO INC | 163,679 | $201K | 0.1% | $1.23 * | $13.58 | -91.5% | COM | 10170A100 |
| APRE | APREA THERAPEUTICS INC | 112,223 | $166K | 0.0% | $1.48 * | $7.27 | -77.4% | COM NEW | 03836J201 |
| TERN | TERNS PHARMACEUTICALS INC | 10,100 | $75,851 | 0.0% | $7.51 * | $8.18 | -21.9% | COM | 880881107 |
| NXTC | NEXTCURE INC | 10,940 | $64,108 | 0.0% | $5.86 * | $5.23 | 0.0% | COM NEW | 65343E207 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 400,000 | $14,440 | 0.0% | $0.04 | $0.16 | — | *W EXP 09/02/202 | 77313F114 |
| HUMAW | HUMACYTE INC | 49,998 | $12,240 | 0.0% | $0.24 | $0.60 | — | *W EXP 08/27/202 | 44486Q111 |